Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$4.07
$0.3058.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.37% | 2.56% | -111.07% | 7.01% | -77.52% |
| Total Depreciation and Amortization | -47.37% | -10.00% | -57.89% | -33.33% | 26.67% |
| Total Amortization of Deferred Charges | -98.54% | -100.00% | -54.04% | -29.61% | -21.47% |
| Total Other Non-Cash Items | 148,850.00% | -134.20% | 271.24% | -26.46% | 100.03% |
| Change in Net Operating Assets | -274.89% | -641.84% | 2,731.05% | 114.28% | -85.30% |
| Cash from Operations | -103.93% | -153.27% | -30.21% | 14.99% | 7.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 24,460.29% | 1,743.95% | 103.43% |
| Cash from Investing | -- | -100.00% | 6,495.75% | 1,743.95% | 103.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 50.00% | -- | -260.42% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -471.75% | -- | -- | -- | 88.41% |
| Cash from Financing | 12,898.50% | 1,431.85% | -- | -231.68% | -101.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 320.11% | 234.66% | 65.47% | 59.19% | 5.62% |